Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Kuusi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medical Teacher|October 9, 2009
Freeware eLearning Flash-ECG for learning electrocardiographyKalle Romanov, Timo Kuusi
European Journal of Heart Failure|January 27, 2009
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptideHans Wedel, John J V McMurray, Magnus Lindberg, et al.
Circulation|November 18, 2009
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysisJohn J V McMurray, John Kjekshus, Lars Gullestad, et al.
The New England Journal of Medicine|November 7, 2007
Rosuvastatin in older patients with systolic heart failureJohn Kjekshus, Eduard Apetrei, Vivencio Barrios, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medical Teacher|October 9, 2009
Freeware eLearning Flash-ECG for learning electrocardiographyKalle Romanov, Timo Kuusi
European Journal of Heart Failure|January 27, 2009
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptideHans Wedel, John J V McMurray, Magnus Lindberg, et al.
Circulation|November 18, 2009
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysisJohn J V McMurray, John Kjekshus, Lars Gullestad, et al.
The New England Journal of Medicine|November 7, 2007
Rosuvastatin in older patients with systolic heart failureJohn Kjekshus, Eduard Apetrei, Vivencio Barrios, et al.
Pageof 1